armagen-logo brain  
 
HomeAbout the BBB
Targeting
ProductsNewsCareersContact Us
 
 

The blood-brain barrier blocks the development of biologic pharmaceuticals for brain 

ArmaGen® provides platform technology solutions to the 'blood-brain barrier' problem, and can non-invasively target recombinant proteins, therapeutic monoclonal antibodies, and siRNA to the brain


 

home_pic
Brain blood vessels form the blood-brain barrier and block drug access to the brain

 

News    December 8, 2011

ArmaGen® granted U.S. patents on IgG-neurotrophin fusion proteins for targeted brain delivery

Brain-penetrating neurotrophins. Three new patents on IgG-neurotrophin fusion proteins for targeted brain drug delivery across the human blood-brain barrier (BBB) have been issued or allowed....

  more news

Home | About the BBB | Targeting - Protein Drugs . Non-Viral Genes . Small Molecules | Products | News | Careers | Contact Us